| 1 |
32165486 | The HDAC and PI3K dual inhibitor CUDC-907 synergistically enhances the antileukemic activity of venetoclax in preclinical models of acute myeloid leukemia. | 2021 May 1 |
1 |
| 2 |
33663586 | Targeting phosphoinositide 3-kinases and histone deacetylases in multiple myeloma. | 2021 Mar 4 |
1 |
| 3 |
32459381 | CUDC-907, a novel dual PI3K and HDAC inhibitor, in prostate cancer: Antitumour activity and molecular mechanism of action. | 2020 Jul |
1 |
| 4 |
30353642 | CUDC-907 blocks multiple pro-survival signals and abrogates microenvironment protection in CLL. | 2019 Jan |
1 |
| 5 |
30819918 | Antileukemic activity and mechanism of action of the novel PI3K and histone deacetylase dual inhibitor CUDC-907 in acute myeloid leukemia. | 2019 Nov |
1 |